NeoPhotonics Corporation (NPTN)

US64051T1007 - Common Stock

16.01  +0.01 (+0.06%)

After market: 16.01 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NPTN. NPTN was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. NPTN may be in some trouble as it scores bad on both profitability and health. NPTN is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

NPTN had negative earnings in the past year.
In the past 5 years NPTN always reported negative net income.
In multiple years NPTN reported negative operating cash flow during the last 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -10.28%
ROE N/A
ROIC -8.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -7.62%
PM (TTM) -10.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NPTN is destroying value.
The number of shares outstanding for NPTN has been increased compared to 1 year ago.
The debt/assets ratio for NPTN is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.22 indicates that NPTN is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.36 indicates that NPTN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC-0.84
WACC10.11%

2.3 Liquidity

A Current Ratio of 2.57 indicates that NPTN has no problem at all paying its short term obligations.
A Quick Ratio of 1.95 indicates that NPTN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.95

4

3. Growth

3.1 Past

The earnings per share for NPTN have decreased strongly by -1050.00% in the last year.
NPTN shows a decrease in Revenue. In the last year, the revenue decreased by -4.80%.
Measured over the past years, NPTN shows a decrease in Revenue. The Revenue has been decreasing by -6.74% on average per year.
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q126.67%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Revenue growth Q2Q46.58%

3.2 Future

NPTN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.02% yearly.
The Revenue is expected to grow by 20.89% on average over the next years. This is a very strong growth
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

NPTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
NPTN is valuated rather expensively with a Price/Forward Earnings ratio of 20.00.
NPTN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -266.15

4.3 Compensation for Growth

NPTN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NPTN's earnings are expected to grow with 77.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.65%
EPS Next 3Y77.09%

0

5. Dividend

5.1 Amount

NPTN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NeoPhotonics Corporation

NYSE:NPTN (8/2/2022, 7:24:07 PM)

After market: 16.01 0 (0%)

16.01

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap859.58M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.28%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -7.62%
PM (TTM) -10.46%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.57
Quick Ratio 1.95
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y169.52%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y